Global Pharmaceutical CDMO Market by Player, Region, Type, Application and Sales Channel
Global Pharmaceutical CDMO Market by Player, Region, Type, Application and Sales Channel
The Pharmaceutical CDMO Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report studies the Pharmaceutical CDMO market, covering market size for segment by type (Active Pharmaceutical Ingredient (API), Finished Dosage Formulation (FDF), etc.), by application (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, etc.), by sales channel (Direct Channel, Distribution Channel), by player (LabCorp, IQVIA, Syneos Health, Quintiles, PPD, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Pharmaceutical CDMO from 2017-2022, and provides extensive market forecasts from 2023-2031 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Pharmaceutical CDMO market.
Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.
This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of Pharmaceutical CDMO including:
LabCorp
IQVIA
Syneos Health
Quintiles
PPD
Parexel
ICON
PRA Health Sciences
InVentiv
INC Research Holdings
CRL
Wuxi AppTec
Charles River
Envigo
Medpace Holdings
SGS
PSI CRO
Axcent Advanced Analytics
BIO Agile Therapeutics
Firma Clinical Research
Acculab Lifesciences
Azelix
CTSERV
PEPGRA
Dove Quality Solutions
Market split by Type, can be divided into:
Active Pharmaceutical Ingredient (API)
Finished Dosage Formulation (FDF)
Others
Market split by Application, can be divided into:
Pharmaceutical & Biopharmaceutical Companies
Medical Device Companies
Academic Institutes
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Chapter 1 Pharmaceutical CDMO Market Overview
1.1 Pharmaceutical CDMO Definition
1.2 Global Pharmaceutical CDMO Market Size Status and Outlook (2017-2031)
1.3 Global Pharmaceutical CDMO Market Size Comparison by Region (2017-2031)
1.4 Global Pharmaceutical CDMO Market Size Comparison by Type (2017-2031)
1.5 Global Pharmaceutical CDMO Market Size Comparison by Application (2017-2031)
1.6 Global Pharmaceutical CDMO Market Size Comparison by Sales Channel (2017-2031)
1.7 Pharmaceutical CDMO Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
Chapter 2 Pharmaceutical CDMO Market Segment Analysis by Player
2.1 Global Pharmaceutical CDMO Sales and Market Share by Player (2020-2022)
2.2 Global Pharmaceutical CDMO Revenue and Market Share by Player (2020-2022)
2.3 Global Pharmaceutical CDMO Average Price by Player (2020-2022)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Pharmaceutical CDMO Market Segment Analysis by Type
3.1 Global Pharmaceutical CDMO Market by Type
3.1.1 Active Pharmaceutical Ingredient (API)
3.1.2 Finished Dosage Formulation (FDF)
3.1.3 Others
3.2 Global Pharmaceutical CDMO Sales and Market Share by Type (2017-2022)
3.3 Global Pharmaceutical CDMO Revenue and Market Share by Type (2017-2022)
3.4 Global Pharmaceutical CDMO Average Price by Type (2017-2022)
3.5 Leading Players of Pharmaceutical CDMO by Type in 2022
3.6 Conclusion of Segment by Type
Chapter 4 Pharmaceutical CDMO Market Segment Analysis by Application
4.1 Global Pharmaceutical CDMO Market by Application
4.1.1 Pharmaceutical & Biopharmaceutical Companies
4.1.2 Medical Device Companies
4.1.3 Academic Institutes
4.2 Global Pharmaceutical CDMO Revenue and Market Share by Application (2017-2022)
4.3 Leading Consumers of Pharmaceutical CDMO by Application in 2022
4.4 Conclusion of Segment by Application
Chapter 5 Pharmaceutical CDMO Market Segment Analysis by Sales Channel
5.1 Global Pharmaceutical CDMO Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Pharmaceutical CDMO Revenue and Market Share by Sales Channel (2017-2022)
5.3 Leading Distributors/Dealers of Pharmaceutical CDMO by Sales Channel in 2022
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Pharmaceutical CDMO Market Segment Analysis by Region
6.1 Global Pharmaceutical CDMO Market Size and CAGR by Region (2017-2031)
6.2 Global Pharmaceutical CDMO Sales and Market Share by Region (2017-2022)
6.3 Global Pharmaceutical CDMO Revenue and Market Share by Region (2017-2022)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Pharmaceutical CDMO Market Share by Type
6.4.3 North America Pharmaceutical CDMO Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Pharmaceutical CDMO Market Share by Type
6.5.3 Europe Pharmaceutical CDMO Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Pharmaceutical CDMO Market Share by Type
6.6.3 Asia-Pacific Pharmaceutical CDMO Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Pharmaceutical CDMO Market Share by Type
6.7.3 South America Pharmaceutical CDMO Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Pharmaceutical CDMO Market Share by Type
6.8.3 Middle East & Africa Pharmaceutical CDMO Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Pharmaceutical CDMO Players
7.1 LabCorp
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 IQVIA
7.3 Syneos Health
7.4 Quintiles
7.5 PPD
7.6 Parexel
7.7 ICON
7.8 PRA Health Sciences
7.9 InVentiv
7.10 INC Research Holdings
7.11 CRL
7.12 Wuxi AppTec
7.13 Charles River
7.14 Envigo
7.15 Medpace Holdings
7.16 SGS
7.17 PSI CRO
7.18 Axcent Advanced Analytics
7.19 BIO Agile Therapeutics
7.20 Firma Clinical Research
7.21 Acculab Lifesciences
7.22 Azelix
7.23 CTSERV
7.24 PEPGRA
7.25 Dove Quality Solutions
Chapter 8 Upstream and Downstream Analysis of Pharmaceutical CDMO
8.1 Industrial Chain of Pharmaceutical CDMO
8.2 Upstream of Pharmaceutical CDMO
8.3 Downstream of Pharmaceutical CDMO
Chapter 9 Development Trend of Pharmaceutical CDMO (2023-2031)
9.1 Global Pharmaceutical CDMO Market Size (Sales and Revenue) Forecast (2023-2031)
9.2 Global Pharmaceutical CDMO Market Size and CAGR Forecast by Region (2023-2031)
9.3 Global Pharmaceutical CDMO Market Size and CAGR Forecast by Type (2023-2031)
9.4 Global Pharmaceutical CDMO Market Size and CAGR Forecast by Application (2023-2031)
9.5 Global Pharmaceutical CDMO Market Size and CAGR Forecast by Sales Channel (2023-2031)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
Research Methodology:
Pharmaceutical CDMO Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|